Biotek-snakken — September 2018
-
Spænd på Zealand i dag. Det er et genialt træk ledelsen har gjort.
-
-
Her er halvårsrapporten fra Oncology Ventures: http://www.oncologyventure.com/my_feeds/oncology-venture-a-s-publicerar-halvarsrapport-for-perioden-januari-juni-2018/
-
TA på Oncology Ventures: Der er lang vej tilbage til toppen... https://www.investtech.com/dk/market.php?CompanyID=46109256
-
Gode data for Onkology Ventures i brys
kræft: -
-
Onkology på InvestorDagen: http://www.proinvestor.com/?p=debat_1&postid=76176&thread=50&start=#76187
-
Jo, der er nyheder. Tidligere Kite chef ansat : https://ir.zymeworks.com/news-releases/2018/09-19-2018-114420342
-
-
Biotec Pharmacon: Stuart Devine skal ikke længere lede salget af Woulgan, Finn Ketler fra Coloplast overtager hans job. Vi må håbe Finn kan få sat gang i salget, det har været en noget skuffende udvikling.
-
-
Dansk cannabisselskab går på Børsen: https://stenocare.dk/Investor/INVESTOR--EN/Company-Introduction
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind